Preclinical serum 25-hydroxyvitamin D levels and risk of type 1 diabetes in a cohort of US military personnel

American Journal of Epidemiology

Volumn 177, Issue 5, 2013, Pages 411-419

  Munger, Kassandra L ^a   Levin, Lynn I ^b   Massa, Jennifer ^b   Horst, Ronald ^b   Orban, Tihamer ^b   Ascherio, Alberto ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

nested case control study; type 1 diabetes; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D;

COHORT ANALYSIS; DIABETES; DISEASE CONTROL; ESTIMATION METHOD; PUBLIC HEALTH; RISK FACTOR; SERUM; VITAMIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISPANIC; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEGRO; SOLDIER;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; MILITARY PERSONNEL; PROSPECTIVE STUDIES; RISK; UNITED STATES; VITAMIN D; VITAMINS;

UNITED STATES;

EID: 84874782679     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws243     Document Type: Article

References (43)

1. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003; 26(suppl 1):S5-S20.
2. Varney MD, Valdes AM, Carlson JA, et al. HLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type 1 diabetes: analysis of the type 1 diabetes genetics consortium families. Diabetes. 2010;59(8):2055- 2062.
3. Todd JA. Etiology of type 1 diabetes. Immunity. 2010; 32(4):457-467.
4. Emery LM, Babu S, Bugawan TL, et al. Newborn HLA-DR DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates. Pediatr Diabetes. 2005;6(3): 136-144.
5. Munger KL, Levin LI, Hollis BW, et al. Serum 25- hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832-2838.
6. Handel AE, Handunnetthi L, Ebers GC, et al. Type 1 diabetes mellitus and multiple sclerosis: common etiological features. Nat Rev Endocrinol. 2009;5(12):655-664.
7. Stene LC, Ulriksen J, Magnus P, et al. Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring. Diabetologia. 2000;43(9):1093-1098.
8. Miettinen ME, Reinert L, Kinnunen L, et al. Serum 25- hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring. Diabetologia. 2012;55(5): 1291-1294.
9. Sorensen IM, Joner G, Jenum PA, et al. Maternal serum levels of 25-hydroxy-vitamin D during pregnancy and risk of type 1 diabetes in the offspring. Diabetes. 2012;61(1): 175-178.
10. Hypponen E, Laara E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001;358(9292):1500-1503.
11. Stene LC, Joner G. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr. 2003;78(6):1128-1134.
12. Simpson M, Brady H, Yin X, et al. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia. 2011;54(11):2779-2788.
13. Rewers M, Norris J, Dabelea D. Epidemiology of type 1 diabetes mellitus. Adv Exp Med Biol. 2004;552:219-246.
14. Rubertone MV, Brundage JF. The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. Am J Public Health. 2002;92(12):1900-1904.
15. Levin LI, Munger KL, Rubertone MV, et al. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA. 2005;293(20):2496-2500.
16. Bliss C. Periodic Regression in Biology and Climatology. New Haven: The Connecticut Agricultural Experimental Station; 1958:3-55.
17. Carter GD, Jones JC, Berry JL. The anomalous behaviour of exogenous 25-hydroxyvitamin D in competitive binding assays. J Steroid Biochem Mol Biol. 2007;103(3-5):480-482.
18. Wagner D, Hanwell HE, Vieth R. An evaluation of automated methods for measurement of serum 25- hydroxyvitamin D. Clin Biochem. 2009;42(15):1549-1556.
19. Pozzilli P, Manfrini S, Crino A, et al. Low levels of 25- hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res. 2005;37(11):680-683.
20. Littorin B, Blom P, Scholin A, et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia. 2006;49(12):2847-2852.
21. Bierschenk L, Alexander J, Wasserfall C, et al. Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care. 2009;32(11): 1977-1979.
22. Greer RM, Rogers MA, Bowling FG, et al. Australian children and adolescents with type 1 diabetes have low vitamin D levels. Med J Aust. 2007;187(1):59-60.
23. Svoren BM, Volkening LK, Wood JR, et al. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. J Pediatr. 2009;154(1):132-134.
24. Wasserfall CH, Atkinson MA. Autoantibody markers for the diagnosis and prediction of type 1 diabetes. Autoimmun Rev. 2006;5(6):424-428.
25. Umpierrez GE, Smiley D, Kitabchi AE. Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med. 2006;144(5):350-357.
26. Umpierrez GE. Ketosis-prone type 2 diabetes: time to revise the classification of diabetes. Diabetes Care. 2006;29(12): 2755-2757.
27. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80(6 suppl): 1678S-1688S.
28. Lucas RM, Ponsonby AL. Considering the potential benefits as well as adverse effects of sun exposure: can all the potential benefits be provided by oral vitamin D supplementation? Prog Biophys Mol Biol. 2006;92(1):140-149.
29. Ahn J, Yu K, Stolzenberg-Solomon R, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet. 2010;19(13):2739-2745.
30. Cooper JD, Smyth DJ, Walker NM, et al. Inherited variation in vitamin d genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes. 2011;60(5): 1624-1631.
31. Steck AK, Rewers MJ. Genetics of type 1 diabetes. Clin Chem. 2011;57(2):176-185.
32. Takiishi T, Gysemans C, Bouillon R, et al. Vitamin D and diabetes. Endocrinol Metab Clin North Am. 2010;39(2): 419-446.
33. Mathieu C, Waer M, Laureys J, et al. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia. 1994;37(6):552-558.
34. Gregori S, Giarratana N, Smiroldo S, et al. A 1α,25- dihydroxyvitamin D3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes. 2002; 51(5):1367-1374.
35. Adorini L, Penna G, Giarratana N, et al. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J Cell Biochem. 2003;88(2):227-233.
36. Sandler S, Buschard K, Bendtzen K. Effects of 1,25- dihydroxyvitamin D3 and the analogues MC903 and KH1060 on interleukin-1 beta-induced inhibition of rat pancreatic islet beta-cell function in vitro. Immunol Lett. 1994;41(1):73-77.
37. Riachy R, Vandewalle B, Moerman E, et al. 1,25- Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor. Apoptosis. 2006;11(2):151-159.
38. Gysemans CA, Cardozo AK, Callewaert H, et al. 1,25- Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology. 2005;146(4):1956-1964.
39. Branisteanu DD, Waer M, Sobis H, et al. Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 alpha, 25-(OH)2D3. J Neuroimmunol. 1995;61(2):151-160.
40. Cantorna MT, Hayes CE, DeLuca HF. 1,25- Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr. 1998;128(1): 68-72.
41. Cantorna MT, Hayes CE, DeLuca HF. 1,25- Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A. 1996;93(15): 7861-7864.
42. Binkley N, Krueger DC, Morgan S, et al. Current status of clinical 25-hydroxyvitamin D measurement: an assessment of between-laboratory agreement. Clin Chim Acta. 2010; 411(23-24):1976-1982.
43. Gorham ED, Garland CF, Burgi AA, et al. Lower prediagnostic serum 25-hydroxyvitamin D concentration is associated with higher risk of insulin-requiring diabetes: a nested case-control study. Diabetologia. 2012;55(12): 3224-3227.